Cytosorbents Corporation (CTSO): Price and Financial Metrics
CTSO Price/Volume Stats
Current price | $1.21 | 52-week high | $1.59 |
Prev. close | $1.15 | 52-week low | $0.70 |
Day low | $1.16 | Volume | 124,131 |
Day high | $1.27 | Avg. volume | 376,880 |
50-day MA | $0.97 | Dividend yield | N/A |
200-day MA | $1.00 | Market Cap | 66.16M |
CTSO Stock Price Chart Interactive Chart >
Cytosorbents Corporation (CTSO) Company Bio
CytoSorbents Corporation, a critical care focused immunotherapy company, engages in the research, development, and commercialization of medical devices with its platform blood purification technology incorporating a proprietary adsorbent polymer technology. The company was founded in 1997 and is based in Monmouth Junction, New Jersey.
CTSO Price Returns
1-mo | 16.35% |
3-mo | 35.20% |
6-mo | 16.35% |
1-year | 19.80% |
3-year | -66.85% |
5-year | -77.08% |
YTD | 32.97% |
2024 | -18.02% |
2023 | -28.39% |
2022 | -63.01% |
2021 | -47.43% |
2020 | 107.01% |
Continue Researching CTSO
Want to see what other sources are saying about Cytosorbents Corp's financials and stock price? Try the links below:Cytosorbents Corp (CTSO) Stock Price | Nasdaq
Cytosorbents Corp (CTSO) Stock Quote, History and News - Yahoo Finance
Cytosorbents Corp (CTSO) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...